Evidence map›Paper›PMID 28768863›Full record

ArticleJournal of virology2017

Vladimir Pecenka, Petr Pajer, Vít Karafiat, Petra Kasparova, Jana Dudlova, Michal Dvorak

Open access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Network analysis of liver cancer: a system biology approach.Gastroenterology and hepatology from bed to bench · 2023
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Vladimir PecenkaInstitute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic pecenkav@img.cas.cz.
Petr PajerInstitute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic.
Vít KarafiatInstitute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic.
Petra KasparovaFingerland's Department of Pathology, School of Medicine, Charles University, Hradec Králové, Czech Republic.
Jana DudlovaChambon s.r.o., Prague, Czech Republic.
Michal DvorakInstitute of Molecular Genetics, Academy of Sciences CR, Prague, Czech Republic.
Czech Academy of Sciences, Institute of Molecular Genetics · CZCharles University · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myeloblastosis-associated virus 2 (MAV-2) is a highly tumorigenic simple avian retrovirus. Chickens infected

Indexed as

CarcinogenesisGenes, erbB-1Mutagenesis, InsertionalAnimalsAvian Myeloblastosis VirusAvian ProteinsCarcinoma, HepatocellularChickensCholangiocarcinomaHemangiosarcomaHumansLiver NeoplasmsOncogenesProto-Oncogene Proteins c-metProvirusesReceptor Protein-Tyrosine KinasesAvian ProteinsProto-Oncogene Proteins c-metReceptor Protein-Tyrosine KinasesRON proteinavian retrovirusesinsertional mutagenesisretroviral oncogenesis

Identifiers

PMID28768863
PMCPMC5625502
OpenAlexW2740775845

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.